The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...
Studies have long warned that blows to the head may raise the risk of neurodegenerative conditions. Now, scientists believe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback